- Financial Times•4 days ago
German generic drugmaker Stada is gearing up for a bitter proxy battle as an activist investor seeks to clear out its board, accusing it of presiding over a culture of poor performance, cronyism and excessive ...
- The Wall Street Journal•9 days ago
Germany is gearing up for a rare proxy fight between activist investors and generic drugmaker Stada Arzneimittel ahead of a shareholder meeting later this month.
- Bloomberg•10 days ago
Stada Arzneimittel AG, the German generic-drug maker that has faced pressure from an activist investor, said longtime leader Hartmut Retzlaff has resigned after going on leave in June to deal with a serious, ...
Stada-Arzneimittel AG (SAZ.DE)
XETRA - XETRA Delayed Price. Currency in EUR
|Bid||48.15 x 5000|
|Ask||48.17 x 28500|
|Day's Range||46.62 - 48.28|
|52wk Range||28.05 - 51.06|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.61|
|Avg Vol (3m)||343,157|
|Dividend & Yield||N/A (N/A)|